CervoMed Inc. (CRVO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $25.57M
Last updated: Nov 17, 2026 at 11:04 AM ET
CervoMed Inc. (CRVO) Earnings: Report Dates and Results
CervoMed (CRVO) is expected to report earnings on Mar 11, 2027. In the quarter ended Sep 30, 2026, CervoMed reported EPS of -$0.39, above the -$0.61 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CRVO has an expected report date of Mar 11, 2027.
Earnings History
Of the 29 quarters below that had an estimate, CRVO beat 11, missed 17 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2023, when EPS landed 168.42% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.39 | -$0.61 | -$0.73 - -$0.23 | +36.07% | Beat | N/A | 5 | 3 up, 1 down | Nov 6, 2026 | N/A |
| Jun 30, 2026 | -$0.64 | -$0.87 | -$0.98 - -$0.74 | +26.44% | Beat | N/A | 5 | 1 up, 3 down | Aug 7, 2026 | N/A |
| Mar 31, 2026 | -$0.86 | -$0.79 | -$0.99 - -$0.17 | -8.46% | Miss | N/A | 7 | 0 up, 3 down | May 18, 2026 | N/A |
| Dec 31, 2025 | -$0.88 | -$0.70 | -$0.89 - -$0.07 | -25.71% | Miss | N/A | 6 | 0 up, 2 down | Mar 13, 2026 | $8726 |
| Sep 30, 2025 | -$0.84 | -$0.64 | -$0.87 - -$0.06 | -31.25% | Miss | N/A | 6 | 0 up, 1 down | Nov 7, 2025 | $322569 |
| Jun 30, 2025 | -$0.70 | -$0.62 | -$0.76 - -$0.39 | -12.90% | Miss | N/A | 5 | 3 up, 0 down | Aug 8, 2025 | $1.76M |
| Mar 31, 2025 | -$0.56 | -$0.62 | -$0.80 - -$0.47 | +10.16% | Beat | N/A | 6 | N/A | May 12, 2025 | $1.92M |
| Dec 31, 2024 | -$0.80 | -$0.63 | -$0.72 - -$0.38 | -26.98% | Miss | N/A | 7 | N/A | Mar 17, 2025 | $2.16M |
| Sep 30, 2024 | -$0.55 | -$0.41 | -$0.50 - -$0.31 | -34.15% | Miss | -184.6% | 4 | 0 up, 0 down | Nov 12, 2024 | $1.94M |
| Jun 30, 2024 | -$0.27 | -$0.29 | -$0.44 - -$0.01 | +6.90% | Beat | N/A | 5 | 0 up, 0 down | Aug 9, 2024 | $3.29M |
| Mar 31, 2024 | -$0.41 | -$0.32 | N/A | -28.13% | Miss | N/A | N/A | 0 up, 0 down | May 14, 2024 | $2.35M |
| Dec 31, 2023 | -$0.38 | -$0.29 | N/A | -31.03% | Miss | N/A | 1 | 0 up, 0 down | Mar 25, 2024 | $2.49M |
| Sep 30, 2023 | $0.65 | -$0.95 | N/A | +168.42% | Beat | N/A | N/A | N/A | Nov 13, 2023 | $1.53M |
| Jun 30, 2023 | -$1.55 | -$1.93 | N/A | +19.64% | Beat | N/A | N/A | N/A | Aug 8, 2023 | $1.72M |
| Mar 31, 2023 | -$2.01 | -$1.91 | N/A | -5.24% | Miss | N/A | N/A | 0 up, 0 down | May 15, 2023 | $1.41M |
| Dec 31, 2022 | -$2.00 | -$2.22 | N/A | +9.91% | Beat | N/A | N/A | 0 up, 0 down | Mar 21, 2023 | N/A |
| Sep 30, 2022 | -$2.06 | -$2.06 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 14, 2022 | N/A |
| Jun 30, 2022 | -$3.09 | -$3.06 | N/A | -0.99% | Miss | N/A | N/A | N/A | Sep 28, 2022 | N/A |
| Mar 31, 2022 | -$3.33 | -$1.75 | N/A | -90.29% | Miss | N/A | N/A | N/A | Jun 28, 2022 | N/A |
| Dec 31, 2021 | -$2.25 | -$2.00 | N/A | -12.50% | Miss | N/A | N/A | N/A | Mar 29, 2022 | N/A |
| Sep 30, 2021 | -$9.00 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | Dec 29, 2021 | N/A |
| Jun 30, 2021 | -$3.00 | -$3.37 | N/A | +11.11% | Beat | N/A | N/A | N/A | Sep 28, 2021 | N/A |
| Mar 31, 2021 | -$4.50 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | May 7, 2021 | N/A |
| Dec 31, 2020 | -$4.50 | -$4.12 | N/A | -9.10% | Miss | -121.4% | N/A | N/A | Mar 31, 2021 | N/A |
| Sep 30, 2020 | -$5.25 | -$4.12 | N/A | -27.28% | Miss | N/A | N/A | N/A | Nov 12, 2020 | N/A |
| Jun 30, 2020 | -$7.50 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | Aug 10, 2020 | N/A |
| Mar 31, 2020 | -$5.25 | -$4.50 | N/A | -16.67% | Miss | N/A | N/A | N/A | May 11, 2020 | N/A |
| Dec 31, 2019 | $21.00 | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | Mar 17, 2020 | N/A |
| Sep 30, 2019 | -$45.00 | -$53.25 | N/A | +15.49% | Beat | N/A | N/A | N/A | Nov 11, 2019 | N/A |
| Jun 30, 2019 | -$47.25 | -$45.00 | N/A | -5.00% | Miss | N/A | N/A | N/A | Aug 8, 2019 | N/A |
| Mar 31, 2019 | -$60.75 | -$68.25 | N/A | +10.98% | Beat | -16086.8% | N/A | N/A | May 9, 2019 | N/A |
| Dec 31, 2018 | -$124.50 | -$96.00 | N/A | -29.69% | Miss | N/A | N/A | N/A | Mar 31, 2019 | N/A |
| Sep 30, 2018 | -$146.25 | -$0.90 | N/A | N/A | N/A | -73225.0% | N/A | N/A | Dec 29, 2018 | N/A |
| Jun 30, 2018 | -$56.25 | -$67.46 | N/A | +16.62% | Beat | N/A | N/A | N/A | Aug 13, 2018 | N/A |
| Mar 31, 2018 | $0.38 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | Apr 3, 2018 | N/A |
| Sep 30, 2017 | $0.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 29, 2017 | N/A |
| Jun 30, 2017 | -$0.54 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 21, 2017 | N/A |
| Mar 31, 2017 | -$1.77 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2017 | N/A |
| Dec 31, 2016 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Mar 31, 2017 | N/A |
| Sep 30, 2016 | -$7.95 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 29, 2016 | N/A |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.98, after -$2.03 the year before. It was -$12,271.14 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.98 | N/A |
| Dec 31, 2024 | -$2.03 | N/A |
| Dec 31, 2023 | -$3.29 | N/A |
| Dec 31, 2022 | -$10.48 | N/A |
| Dec 31, 2021 | -$18.75 | N/A |
| Dec 31, 2020 | -$22.50 | N/A |
| Dec 31, 2019 | -$132.00 | N/A |
| Dec 31, 2018 | -$328.73 | N/A |
| Dec 31, 2016 | -$1,125.57 | N/A |
| Dec 31, 2015 | -$12,271.14 | N/A |
Frequently Asked Questions About CRVO
When is CervoMed's next earnings date?
CervoMed's next earnings report is expected for Mar 11, 2027.
Did CRVO beat earnings estimates last quarter?
Yes. CervoMed reported EPS of -$0.39 for the quarter ended Sep 30, 2026, above the -$0.61 estimate, a 36.07% surprise.
What EPS do analysts expect from CRVO next quarter?
The consensus EPS estimate for CervoMed for the quarter ending Dec 31, 2026 is -$0.53 from 8 analysts, with estimates from -$0.74 to -$0.43.
How often does CRVO beat earnings estimates?
CervoMed beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -4.08%.
CRVO pages: Overview, Earnings, Forecast, Financials, Competitors